타겟 시퀀싱 시장 : 세계 산업 규모, 점유율, 동향, 경쟁, 기회, 예측 - 제품 유형별, 타겟 농축법별, 타겟 포착 유형별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Targeted Sequencing Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Product Type, By Target Enrichment Method, By Target Capture Type, By Application, By End Users, By Region, By Competition, 2020-2030F
상품코드:1878817
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 타겟 시퀀싱 시장은 2024년에 39억 달러로 평가되었으며, 2030년까지 CAGR 11.10%로 성장하여 73억 3,000만 달러에 달할 것으로 예측됩니다.
세계 표적 시퀀싱 시장은 전체 유전체를 시퀀싱하는 것이 아니라 특정 유전자나 엑손 등 특정 유전체 영역을 정확하게 표적화하여 분석하는 차세대 시퀀싱 기술을 중심으로 전개되고 있습니다. 이러한 집중적인 접근 방식은 선택된 영역에 대해 높은 깊이의 커버리지와 정확도를 제공하여 다양한 응용 분야에서 중요한 유전적 변이를 효율적이고 비용 효율적인 방식으로 식별할 수 있도록 합니다.
The Global Targeted Sequencing Market, valued at USD 3.9 Billion in 2024, is projected to experience a CAGR of 11.10% to reach USD 7.33 Billion by 2030. The Global Targeted Sequencing Market centers on a next-generation sequencing technique that precisely targets and analyzes specific genomic regions, such as particular genes or exons, rather than sequencing the entire genome. This focused approach provides high-depth coverage and accuracy for selected areas, enabling efficient and cost-effective identification of genetic variants critical for various applications.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 3.9 Billion
Market Size 2030
USD 7.33 Billion
CAGR 2025-2030
11.1%
Fastest Growing Segment
Targeted DNA Sequencing
Largest Market
North America
Key Market Drivers
The increasing global burden of genetic disorders and cancer represents a primary driving force behind the expansion of the Global Targeted Sequencing Market. The critical need for precise diagnostic tools and methods for disease characterization fuels the demand for targeted sequencing, which offers highly accurate and in-depth analysis of specific genomic regions relevant to these conditions. This technology enables earlier detection, guides personalized treatment strategies, and facilitates monitoring for recurrence or treatment response in oncology and rare disease settings. According to the World Health Organization, in February 2024, global cancer estimates for 2022 revealed approximately 20 million new cancer cases and 9.7 million deaths, highlighting the pervasive nature of this disease and the continuous requirement for advanced diagnostic solutions. Furthermore, targeted sequencing is instrumental in identifying the underlying genetic causes of rare diseases, which collectively affect millions worldwide.
Key Market Challenges
A significant challenge impeding the growth of the Global Targeted Sequencing Market is the absence of standardized guidelines and a unified consensus regarding the multitude of next-generation sequencing platforms and techniques. This fragmented landscape directly complicates widespread clinical adoption and the crucial processes of securing reimbursement for these advanced diagnostic tests. The lack of uniform standards creates ambiguity in test validation, interpretation, and reporting across different laboratories and healthcare providers.
This absence of standardization contributes to inconsistent payer policies, as each insurer may establish varying evidentiary requirements for assessing clinical utility, leading to unpredictable coverage and payment decisions. For instance, according to the College of American Pathologists, a 2.5% reduction in payment for pathology services, which includes molecular diagnostics, is anticipated starting January 2025, reflecting ongoing pressures on reimbursement and the complexities in valuing these intricate tests. Such financial uncertainty directly deters broader integration of targeted sequencing into routine clinical practice, limiting patient access to these critical diagnostic tools and consequently hindering overall market expansion.
Key Market Trends
Artificial intelligence and machine learning integration is profoundly transforming genomic data interpretation within targeted sequencing. These advanced computational methods are essential for efficiently analyzing the vast and complex datasets generated, enabling the rapid identification of subtle genetic variants and their clinical implications. This capability significantly enhances diagnostic precision and facilitates the development of personalized therapeutic approaches. Reflecting this growing importance, according to Roche, in April 2025, the company committed $50 billion over five years to its US pharmaceutical and diagnostics operations, including the establishment of a new research and development center focused on artificial intelligence research. This strategic investment highlights the industry's reliance on AI to convert genomic information into actionable clinical intelligence.
Key Market Players
MGI Tech Co., Ltd
GENEWIZ Inc
Agilent Technologies, Inc.
Daicel Arbor Biosciences
Danaher Corporation
Illumina, Inc.
LGC Biosearch Technologies
Pacific Biosciences of California Inc
CD Genomics
F. Hoffmann-La Roche Ltd
Report Scope:
In this report, the Global Targeted Sequencing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Targeted Sequencing Market, By Product Type:
Kits/Panels and Assays
Instruments
Other
Targeted Sequencing Market, By Target Capture Type:
Targeted DNA Sequencing
Targeted RNA Sequencing
Others
Targeted Sequencing Market, By Target Enrichment Method:
Amplicon Sequencing
Hybridization Capture
Others
Targeted Sequencing Market, By End Users:
Academic and Research Institution
Pharmaceutical and Biotech Companies
Diagnostic & Clinical Laboratories
Other
Targeted Sequencing Market, By Application:
Oncology
Infectious Diseases
Cardiovascular Diseases
Reproductive Health
Rare Diseases
Neurological Disorders
Hereditary Diseases
Others
Targeted Sequencing Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Targeted Sequencing Market.
Available Customizations:
Global Targeted Sequencing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Targeted Sequencing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Kits/Panels and Assays, Instruments, Other)
5.2.2. By Target Capture Type (Targeted DNA Sequencing, Targeted RNA Sequencing, Others)
5.2.3. By Target Enrichment Method (Amplicon Sequencing, Hybridization Capture, Others)
5.2.4. By End Users (Academic and Research Institution, Pharmaceutical and Biotech Companies, Diagnostic & Clinical Laboratories, Other)
